8月26日，阿里健康盘中上涨3.12%，报3.29港元，成交额9081.65万港元。
消息面上，此前母公司阿里巴巴宣布800亿港元新股配售用于AI基础设施建设，8月24日阿里健康一度下跌3.07%。经过短暂消化后，市场情绪趋于平稳，母公司阿里巴巴-W同日反弹2.63%，带动关联标的修复。此外，阿里健康近期在AI医疗领域动作频繁，旗下医学AI平台"氢离子"已获全球三大医学顶刊内容授权，GLP-1RA药物战略合作亦在推进中，基本面催化叠加超跌修复共同支撑股价回升。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.